Corporate Partner Program

The COPD Foundation appreciates the support of our Corporate Partners for achieving our shared goals of undertaking initiatives within the respiratory space relating to chronic obstructive pulmonary disease (COPD), bronchiectasis and nontuberculous mycobacterium (NTM) lung disease. The Corporate Partner Program gives the Foundation greater financial flexibility to take on critical mission-based work and support the greater respiratory community.


The COPD Foundation welcomes the support of corporate sponsors who seek to improve the lives of those affected by COPD, bronchiectasis and NTM lung disease. To join, potential sponsors must demonstrate a commitment to the patient/caregiver community and the Foundation's mission, principles, public positions, policies and standards.

Corporate relationships must follow a number of basic requirements. While the COPD Foundation accepts financial support and other benefits from corporations, the COPD Foundation will always exercise independent judgment in all its decision-making.

For more information about the COPD Foundation Corporate Partner Program please contact Elisha Malanga at emalanga@copdfoundation.org.


The COPD Foundation thanks the organizations below for their participation in the 2022 Corporate Partner Program.


Tier 4

Insmed
AstraZeneca
Pfizer

Tier 3

Theravance Biopharma
Viatris

Tier 2

Verona Pharma
Novartis